AdeiraPharma
Targeted drug formulation technologies for next-generation therapeutics.
Adeira Pharma has developed proprietary targeted nanoparticle formulations for small molecule, protein, nucleic acid and antibody therapeutics. The capabilities of this technology have been amply demonstrated with existing therapeutics that have historically posed formidable formulation challenges, resulting in vigorous efficacy and reduced toxicity in animal models of disease.